CMND
NASDAQ
$1.87
Clearmind Medicine Inc (CMND)
Clearmind Medicine Inc., a preclinical pharmaceutical company, develops new psychedelic drugs to treat neglected health problems. The company is headquartered in Vancouver, Canada.
Sector:
Healthcare
Industry:
Biotechnology
Market Cap
$2.12M
P/B Ratio
0.25
FCF 5Y CAGR
+101.71%
Beta (5Y)
0.25
Price Chart
Valuation
Market Cap$2.12M
P/B0.25
Profitability
EBITDA-$5.41M
EPS-$3.92
Financial Health
Debt-to-Equity0.7%
Growth & Risk
FCF 5Y CAGR+101.71%
Beta (5Y)0.25
Sharpe Ratio-2.50